Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
430 participants
INTERVENTIONAL
2014-02-28
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cat-PAD Follow on Study
NCT01272323
Effectiveness of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects
NCT00729508
Safety of Cat-PAD in Cat Allergic Subjects
NCT00685711
Cat-PAD Exposure Chamber Study
NCT01033344
Safety of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects With Controlled Asthma
NCT00867906
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cat-PAD Treatment 1
Received Cat-PAD Treatment 1 in Study CP007 \[NCT01620762\].No further treatment received in CP007A
Received Cat-PAD Treatment 1 in Study CP007 [NCT01620762]
Cat-PAD Treatment 2
Received Cat-PAD Treatment 2 in Study CP007 \[NCT01620762\].No further treatment received in CP007A.
Received Cat-PAD Treatment 2 in Study CP007 [NCT01620762]
Cat-PAD Treatment 3
Received Cat-PAD Treatment 3 in Study CP007 \[NCT01620762\]. No further treatment received in CP007A.
Received Cat-PAD Treatment 3 in Study CP007 [NCT01620762]
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Received Cat-PAD Treatment 1 in Study CP007 [NCT01620762]
Received Cat-PAD Treatment 2 in Study CP007 [NCT01620762]
Received Cat-PAD Treatment 3 in Study CP007 [NCT01620762]
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Institutionalised due to a legal or regulatory order
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Circassia Limited
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jörg Kleine-Tebbe, MD
Role: PRINCIPAL_INVESTIGATOR
Clinical Research Center for Dermatology, Allergy & Asthma
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP007 A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.